[1] QIN X,HUO Y.H-Type hypertension,stroke and diabetes in China:Opportunities for primary prevention[J].J Diabetes,2016,8(1):38-40.
[2] 吴军,王天义,吴小冬.高同型半胱氨酸血症与慢性肾脏病的相关性研究[J].中国现代医学杂志,2016,26(14):103-107.
[3] 何小波,王晓燕.老年帕金森病患者骨质疏松发生率及其与同型半胱氨酸的关系[J].浙江临床医学,2016,18(4):672-673.
[4] 贾建平.神经病学[M].6版.北京:人民卫生出版社,2008:171.
[5] 裴少芳,金兴中,刘毅.脑卒中发病年龄变化趋势及青年患者的危险因素分析[J].神经疾病与精神卫生,2010(3):263-265.
[6] 周宪梁,胡爱华.MTHFR基因多态性及血浆同型半胱氨酸水平与脑卒中的关系[J].中华心血管病杂志,1999,27(2):121-123.
[7] REFSUM H,SMITH A D,UELAND P M,et al.Facts and recommendations about total homocysteine determinations:an expert opinion[J].Clin Chem,2004,50(1):3-32.
[8] MUDD S H,FINKELSTEIN J D,REFSUM H,et al.Homocysteine and its disulfide derivatives[J].Arterioscler Thromb Vasc Biol,2000,20(7):1704-1706.
[9] MCCULLY K S.Vascular pathology of homocysteinemia:implications for the pathogenesis of arteriosclerosis[J].Am J Pathol,1969,56(1):111.
[10] 田智斌.高同型半胱氨酸血症与脑卒中的关系探讨[J].医药论坛杂志,2011,32(21):121-122.
[11] 宋春霞,李亚军,张世俊,等.血同型半胱氨酸水平与缺血性脑卒中严重程度的关系[J].中风与神经疾病杂志,2011,28(6):547-548.
[12] WALD D S,LAW M,MORRIS J K.Homocysteine and cardiovascular disease:evidence on causality from a meta-analysis[J].BMJ,2002,325(7374):1202.
[13] REINER A P,KUMAR P N,SCHWARTZ S M,et al.Genetic variants of platelet glycoprotein receptors and risk of stroke in young women[J].Stroke,2000,31(7):1628-1633.
[14] TAN N C,VENKETASUBRAMANIAN N,SAW S M,et al.Hyperhomocyst(e) inemia and risk of ischemic stroke among young Asian adults[J].Stroke,2002,33(8):1956-1962.
[15] 李忠.血浆同型半胱氨酸水平与青年缺血性脑卒中关系的研究[D].中国医科大学,2009.
[16] 步霄,贾师捷,朱喜红,等.不同类型脑卒中患者血清同型半胱氨酸水平检测的临床意义[J].现代生物医学进展,2015(15):2925-2928.
[17] 刘国峰,徐文俭,孙顺成.不同年龄组急性脑梗死与血浆同型半胱氨酸水平的关系[J].中风与神经病学杂志,2010,27(7):659-659. |